Novel expression of coat proteins from thermophilic bacteriophage ΦIN93 and evaluation for assembly into virus-like particles

Virus-like particles (VLPs) have the potential to be used as display platforms to develop vaccines against infectious and non-infectious agents. However, most VLPs used as vaccine display platforms are derived from viruses that infect humans; unfortunately, most humans already have pre-existing anti...

Full description

Saved in:
Bibliographic Details
Published inProtein expression and purification Vol. 187; p. 105932
Main Authors Zhai, Lukai, Anderson, Dana, Bruckner, Elizabeth, Tumban, Ebenezer
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2021
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Virus-like particles (VLPs) have the potential to be used as display platforms to develop vaccines against infectious and non-infectious agents. However, most VLPs used as vaccine display platforms are derived from viruses that infect humans; unfortunately, most humans already have pre-existing antibodies against these platforms and thus, the immunogenicity of these vaccines may be compromised. VLP platforms derived from viruses that infect bacteria (bacteriophages), especially bacteriophages that infect bacteria, which do not colonize humans are less likely to have pre-existing antibodies against the platforms in the human population. In this study, we assessed whether two putative coat proteins (ORF13 and ORF14) derived from a thermophilic bacteriophage (ΦIN93) can be expressed and purified from a mesophilic bacterium such as E. coli. We also assessed whether expressed coat proteins can assemble to form VLPs. Truncated versions of ORF13 and ORF14 were successfully co-expressed in bacteria; the co-expressed truncated proteins formed oval structures that look like VLPs, but their sizes were less than those of an authentic ΦIN93 virus. [Display omitted] •Expression of coat proteins (ORF13 & ORF14) from a thermophilic bacteriophage, ΦIN93.•ORF13 and ORF14 were successfully expressed separately in a mesophilic bacterium.•ORF13 and ORF14 were co-expressed using two incompatible plasmids.•Co-expressing ORF13-trunc & ORF14-trunc gave rise to structures that resemble VLPs.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
LZ and ET conceived and designed the experiments. LZ, DA, and EB performed the experiments. LZ and ET analyzed the data and wrote the manuscript
Lukai Zhai developed the expression vectors, expressed & purified the coat proteins, conducted TEM assays, and immunized mice; Dana Anderson helped with protein expression and purification; Elizabeth Bruckner helped with immunization studies and collection of sera from immunized mice; Ebenezer Tumban conceptualized the experiments. Lukai Zhai and Ebenezer Tumban wrote the manuscript.
Author Statement
Authors’ contribution
ISSN:1046-5928
1096-0279
DOI:10.1016/j.pep.2021.105932